Inovio Pharmaceuticals Inc Strategic Asset Allocation Index
Inovio Pharmaceuticals Inc strategic asset allocation index. Inovio Pharmaceuticals Inc (INO) has a Strategic Asset Allocation Index of 10.8% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $3.09 Million) total $3.09 Million, measured against net assets of $28.53 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Inovio Pharmaceuticals Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Inovio Pharmaceuticals Inc (1999–2024)
Strategic asset allocation index of Inovio Pharmaceuticals Inc from 1999 to 2024. This chart shows how Inovio Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 26 annual periods from 1999 to 2024. As of June 2025, the index stands at 10.8%, representing strategic assets of $3.09 Million against net assets of $28.53 Million USD. Check tangible equity quality of Inovio Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Inovio Pharmaceuticals Inc Strategic Asset Allocation Index by Year (1999–2024)
Inovio Pharmaceuticals Inc strategic asset allocation index by year from 1999 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Inovio Pharmaceuticals Inc from 1999 to 2024, covering 26 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Inovio Pharmaceuticals Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.4% | $1.61 Million | $- | $1.61 Million | $68.50 Million | ▼ 0.0 pp |
| 2023 | 2.4% | $2.78 Million | $- | $2.78 Million | $117.35 Million | ▼ -2.0 pp |
| 2022 | 4.4% | $9.74 Million | $7.73 Million | $2.01 Million | $222.36 Million | ▼ -1.0 pp |
| 2021 | 5.3% | $21.36 Million | $17.45 Million | $3.91 Million | $399.67 Million | ▲ +2.8 pp |
| 2020 | 2.6% | $11.78 Million | $11.35 Million | $434.39K | $461.14 Million | ▼ -350.6 pp |
| 2019 | 353.2% | $19.09 Million | $12.77 Million | $6.32 Million | $5.40 Million | ▲ +327.5 pp |
| 2018 | 25.7% | $22.33 Million | $15.95 Million | $6.38 Million | $87.03 Million | ▲ +6.4 pp |
| 2017 | 19.2% | $27.39 Million | $18.32 Million | $9.07 Million | $142.49 Million | ▼ -4.2 pp |
| 2016 | 23.4% | $28.86 Million | $9.03 Million | $19.83 Million | $123.38 Million | ▲ +7.9 pp |
| 2015 | 15.5% | $27.30 Million | $7.31 Million | $19.99 Million | $175.93 Million | ▼ -0.1 pp |
| 2014 | 15.7% | $17.47 Million | $4.58 Million | $12.89 Million | $111.54 Million | ▲ +10.2 pp |
| 2013 | 5.5% | $2.89 Million | $2.89 Million | $- | $52.90 Million | ▲ +4.4 pp |
| 2012 | 1.0% | $363.02K | $363.02K | $- | $34.86 Million | ▼ -18.7 pp |
| 2011 | 19.8% | $9.47 Million | $295.79K | $9.17 Million | $47.86 Million | ▲ +19.2 pp |
| 2010 | 0.6% | $277.00K | $277.00K | $- | $47.10 Million | ▲ +0.0 pp |
| 2009 | 0.6% | $343.00K | $343.00K | $- | $61.18 Million | ▼ -1.3 pp |
| 2008 | 1.9% | $354.00K | $354.00K | $- | $19.11 Million | ▲ +0.6 pp |
| 2007 | 1.3% | $402.00K | $402.00K | $- | $31.03 Million | ▼ -0.4 pp |
| 2006 | 1.7% | $391.00K | $391.00K | $- | $23.50 Million | ▲ +0.1 pp |
| 2005 | 1.6% | $376.00K | $376.00K | $- | $23.47 Million | ▲ +0.6 pp |
| 2004 | 1.0% | $155.00K | $155.00K | $- | $15.55 Million | ▼ -0.2 pp |
| 2003 | 1.2% | $176.00K | $176.00K | $- | $15.05 Million | ▼ -6.7 pp |
| 2002 | 7.9% | $295.00K | $295.00K | $- | $3.73 Million | ▼ -5.1 pp |
| 2001 | 13.1% | $648.00K | $648.00K | $- | $4.96 Million | ▲ +3.9 pp |
| 2000 | 9.1% | $904.00K | $904.00K | $- | $9.89 Million | ▲ +0.6 pp |
| 1999 | 8.6% | $1.01 Million | $1.01 Million | $- | $11.83 Million | — |